Fidelity Blue Chip Value ETF (FBCV) seeks to track the Fidelity Blue Chip Value Index, which measures the performance of large-capitalization U.S. stocks trading at discounts to their intrinsic value based on fundamental metrics like price-to-earnings, price-to-book, and price-to-sales ratios.
How It Works
FBCV uses a passively managed, market-capitalization-weighted approach that selects blue-chip companies exhibiting value characteristics from the largest U.S. stocks. The underlying index screens for companies with low valuation multiples relative to earnings, book value, and sales while maintaining quality standards. Holdings are weighted by market cap and rebalanced quarterly to maintain value factor exposure while avoiding excessive concentration in any single stock or sector.
Key Features
- Zero expense ratio makes it one of the most cost-effective value ETFs available, eliminating annual fees entirely
- Focuses specifically on blue-chip value stocks, combining quality large-cap stability with value factor exposure
- Launched in 2020 by Fidelity, leveraging their decades of value investing expertise and index construction methodology
Risks
- This ETF can lose value when value stocks underperform growth stocks, as occurred during 2020-2021 when technology and growth names surged
- Value factor can experience prolonged periods of underperformance lasting several years, testing investor patience and conviction in the strategy
- Large-cap equity exposure means potential 20-30% declines during broad market downturns, though blue-chip focus may provide some defensive characteristics
Who Should Own This
Best suited for long-term investors with 3+ year time horizons seeking value factor exposure as a satellite holding (10-25% of equity allocation). Medium risk tolerance required due to value factor volatility and potential multi-year underperformance periods. Appeals to investors believing value stocks are undervalued relative to growth stocks.